[Effect of a decarboxylase inhibitor on the effects of dopa & dops on blood pressure].
D000978:Antiparkinson Agents; D001794:Blood Pressure / Q000187:drug effects*; D001795:Blood Pressure Determination; D002262:Carboxy-Lyases; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D015103:Droxidopa; D004791:Enzyme Inhibitors; D006801:Humans; D008190:Lyases / Q000037:antagonists & inhibitors*; D012694:Serine / Q000031:analogs & derivatives
D000978:Antiparkinson Agents; D004791:Enzyme Inhibitors; D012694:Serine; D004295:Dihydroxyphenylalanine; D008190:Lyases; D002262:Carboxy-Lyases; D015103:Droxidopa
BLOOD PRESSURE/effect of drugs on; DESMOLASES/antagonists; DOPA/effects; SERINE/related compounds
Die Beeinflussung der Blutdruckwirkung von Dopa und Dops durch einen Decarboxylase-Inhibitor.